Data / Research funding / California / Vivreon Biosciences, LLC
Vivreon Biosciences, LLC: 12 NIH awards ($12.9M), fiscal years 2021 to 2026
Vivreon Biosciences, LLC in San Diego, CA is funded under 12 NIH awards ($12.9M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- P935LHN98ZV9
- State
- California
Awards
12 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,819,585 | July 15, 2023 | June 30, 2027 | GREENBERG, MILTON L | reporter.nih.gov |
| Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2023 | $2,549,974 | September 15, 2022 | May 31, 2025 | GREENBERG, MILTON L | reporter.nih.gov |
| Predevelopment of VV8220, a Gut-selective CRAC Channel Therapeutic for Ulcerative Colitis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,999,994 | May 1, 2022 | July 31, 2027 | GREENBERG, MILTON L | reporter.nih.gov |
| Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $1,996,385 | July 1, 2025 | March 31, 2027 | GREENBERG, MILTON L | reporter.nih.gov |
| IND-Enabling Toxicology for a Novel Ca2+ Channel Therapeutic to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy | NIH | National Cancer Institute | 2022 to 2024 | $1,873,040 | June 1, 2022 | November 30, 2025 | GREENBERG, MILTON L | reporter.nih.gov |
| Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 | $352,030 | April 15, 2023 | March 31, 2025 | GREENBERG, MILTON L | reporter.nih.gov |
| Development of a Novel Calcium Channel Therapeutic for Dystrophinopathies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $306,872 | September 1, 2024 | July 31, 2025 | GREENBERG, MILTON L | reporter.nih.gov |
| Predevelopment of VV8220, a Gut-selective CRAC Channel Therapeutic for Ulcerative Colitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $299,989 | May 1, 2022 | April 30, 2024 | GREENBERG, MILTON L | reporter.nih.gov |
| Predevelopment of VV8321, a Novel CRAC Channel Therapeutic for the Treatment of Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $252,039 | September 22, 2021 | March 31, 2023 | GREENBERG, MILTON L | reporter.nih.gov |
| Development of a Novel CRAC Channel Therapeutic for the Treatment of Primary Hyperhidrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $245,256 | September 15, 2022 | November 30, 2024 | GREENBERG, MILTON L | reporter.nih.gov |
| Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $193,392 | September 30, 2016 | May 31, 2022 | GREENBERG, MILTON L | reporter.nih.gov |
| Investigation of Microglial CRAC Channels as a Novel Drug Target for Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2021 | $55,000 | May 24, 2021 | August 31, 2022 | GREENBERG, MILTON L | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3 | $4,094,236 | 0 | $0 |
| 2024 | 4 | $3,210,619 | 0 | $0 |
| 2023 | 3 | $1,945,399 | 0 | $0 |
| 2022 | 4 | $3,192,871 | 0 | $0 |
| 2021 | 3 | $500,431 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Neurosciences
- Aging
- Brain Disorders
- Prevention
- Acquired Cognitive Impairment
- Alzheimer's Disease
- Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
- Dementia
- Neurodegenerative
- Genetics
- Digestive Diseases
- Translational Research
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.